Currently, there are five clinical trials registered on clinicaltrials.gov aiming to investigate the efficacy of anti-PD-1 antibodies in treating COVID-19 (NCT04333914, NCT04268537, NCT04356508, NCT04343144, NCT04413838). The gene discussed is PDCD1; the disease is COVID-19.